Bayer Announces Exclusive Licence Agreement with Cedilla Therapeutics

Bayer and Cedilla Therapeutics have recently entered into an exclusive licence agreement to collaborate on the development and commercialisation of Cedilla Therapeutics' CyclinE1/CDK2 complex inhibitors. As part of the agreement, Cedilla will receive an initial payment and may also be eligible for additional milestone payments linked to the progress of development and commercialisation efforts. In addition, Cedilla will receive royalties from any drugs derived from their technology that Bayer successfully brings to market. Cyclin E, a binding partner of Cyclin Dependant Kinase 2 (CDK2), plays a crucial role in the development of certain cancers through overexpression or genetic activation. This unique approach allows for precise targeting of the cyclin E/CDK2 complex, specifically in a patient population with a high unmet medical need. By selectively inhibiting this complex, Cedilla's small molecules have the potential to offer enhanced safety and efficacy compared to existing standard-of-care treatments. This innovative method of action holds promise for addressing the underlying oncogenic processes and improving outcomes for patients in need of more effective therapeutic options.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!